<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00447889</url>
  </required_header>
  <id_info>
    <org_study_id>DGD-44-042</org_study_id>
    <nct_id>NCT00447889</nct_id>
  </id_info>
  <brief_title>A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography</brief_title>
  <official_title>A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guerbet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guerbet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical study of gadoteric acid in non-coronary MR angiography.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Arterial Occlusive Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gadoteric acid</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, at least the age of legal maturity

          -  Strongly suspected of having non-coronary arterial disease, detected clinically

          -  Scheduled to undergo x-ray angiography examination

          -  Female patients must be using effective contraception or be surgically sterilized or
             post-menopausal.

          -  Females of childbearing potential must have a documented negative urine pregnancy
             test.

        Exclusion Criteria:

          -  Contraindication to magnetic resonance imaging (MRI)

          -  Any metallic medical device in the vascular territory for which the patient is to
             undergo imaging examinations

          -  Congenital morphologic vascular abnormalities

          -  Known allergy to gadolinium chelates

          -  Pregnant, breast feeding, or planning to become pregnant during the trial

          -  Received a gadolinium complex within 2 days or iron oxide nanoparticles within 7 days
             before the gadoteric acid-enhanced magnetic resonance angiography (MRA) examination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corinne Dubourdieu, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Guerbet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2007</study_first_submitted>
  <study_first_submitted_qc>March 14, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2007</study_first_posted>
  <last_update_submitted>November 25, 2008</last_update_submitted>
  <last_update_submitted_qc>November 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 26, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

